Corrigendum to 'Butaselen prevents hepatocarcinogenesis and progression through inhibiting thioredoxin reductase activity' [Redox Biol. 14 (2018) 237-249]

Affiliations

• ¹ State Key Laboratory of Natural and Biomimetic Drugs, NO.38, Xueyuan Road, Beijing, 100191, PR China; Department of Chemical Biology, School of Pharmaceutical Sciences, Peking University, NO.38, Xueyuan Road, Beijing, 100191, PR China.
• ² Keaise Center for Clinical Laboratory, NO.666, Gaoxin Road, Wuhan, 430000, PR China.
• ³ National Institutes for Food and Drug Control, NO.2, Tiantanxili, Beijing, 100050, China.
• ⁴ Department of Pharmacology and Molecular Sciences, Johns Hopkins University School of Medicine, Baltimore, MD, 21287, USA.
• ⁵ State Key Laboratory of Natural and Biomimetic Drugs, NO.38, Xueyuan Road, Beijing, 100191, PR China; Department of Chemical Biology, School of Pharmaceutical Sciences, Peking University, NO.38, Xueyuan Road, Beijing, 100191, PR China. Electronic address: zenghh@bjmu.edu.cn.